ARTICLE
|
doi:10.20944/preprints201804.0374.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
STAT3 as a drug target; cyclic STAT3 decoy; oligodeoxynucleotide inhibitor; head and neck cancer
Online: 29 April 2018 (10:10:00 CEST)